The application of new bladder cancer marker protein,peripurakin, to urinary cytology and functional analysis.
| Project/Area Number |
20791125
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Urology
|
|---|
| Research Institution | Jikei University School of Medicine |
|---|
Principal Investigator |
HIROSHI Sasaki Jikei University School of Medicine, 医学部, 助教 (80349589)
|
|---|
| Project Period (FY) |
2008 – 2009
|
| Project Status |
Completed (Fiscal Year 2009)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2009: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2008: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 尿器上皮癌 / プロテオミクス / ペリプラキン / マーカー / 尿細胞診 / 尿路上皮癌 / 膀胱癌 |
|---|
| Research Abstract |
We found the novel cancer marker protein, periplakin, which disappeared appearance by proteomics analysis of the large molecular weight in bladder cancer. We aimed to establish the noncritical inspection method in urine and examining the PPL appearance in the immunohistochemical analysis. In this study, PPL appearance by the shift epithelial cell in urine has significantly decreased in the cancer patient group compared with the control group. Consequently, it was done by immunostaining of PPL and urinary cytology and using it together the possibility of improving the diagnosis.
|
Report
(3 results)
Research Products
(3 results)
